GGrantIndex
← Search

PHASE IIA TRIAL TESTING ERLOTINIB AS AN INTERVENTION AGAINST INTRADUCTAL PANCREA

$1,374M01FY2008RRNIH

University Of California, San Diego, La Jolla CA

Investigators

Linked publications, trials & patents

View original record on NIH RePORTER →
PHASE IIA TRIAL TESTING ERLOTINIB AS AN INTERVENTION AGAINST INTRADUCTAL PANCREA · GrantIndex